Holon, Israel

Michal Rosenthal

This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Collplant Ltd.. Active years: 2014.


% Patents Active = 100.0

 

Average Co-Inventor Count = 6.0

ph-index = 1

Forward Citations = 10(Granted Patents)


Company Filing History:


Years Active: 2014

Loading Chart...
Loading Chart...
1 patent (USPTO):Explore Patents

Title: Michal Rosenthal: Innovator in Recombinant Procollagen Processing

Introduction

Michal Rosenthal is a notable inventor based in Holon, Israel. He has made significant contributions to the field of biotechnology, particularly in the processing of recombinant procollagen. His innovative methods have the potential to impact various applications in medicine and cosmetics.

Latest Patents

Rosenthal holds 1 patent for his work titled "Methods of processing recombinant procollagen." This patent discloses a method for generating atelocollagen by contacting human telopeptide-comprising collagen with specific proteases. The method utilizes non-animal cells for expression, leading to the generation of atelocollagen, which has various applications in medical and cosmetic fields.

Career Highlights

Throughout his career, Michal Rosenthal has been associated with Collplant Ltd., a company focused on developing innovative solutions in regenerative medicine. His work has been instrumental in advancing the understanding and application of collagen-based products.

Collaborations

Rosenthal has collaborated with notable colleagues, including Oded Shoseyov and Hanan Stein. These partnerships have contributed to the development of cutting-edge technologies in the field of biotechnology.

Conclusion

Michal Rosenthal's contributions to the field of recombinant procollagen processing highlight his role as an innovator in biotechnology. His patented methods and collaborations continue to pave the way for advancements in medical and cosmetic applications.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…